- Home
- Products
- Customized FluoroAb™
- IgG Fc
- Anti-IgG Fc MAb (Clone 9)-iFluor® 350 Succinimidyl Ester
Anti-IgG Fc MAb (Clone 9)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS577)
- TARGET
- ANTIBODY
- DYE
- Name
- IgG Fc
- Overview
- Anti-mouse IgG Antibody (Clone 9)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS577. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-AA-021 | anti-MIgG(Fc)-C-MMAE ADC | Cleavable linkers | MMAE (Monomethyl auristatin E) |
| ADC-AA-053 | Protein A-MMAF ADC | MMAF (Monomethyl auristatin F) | |
| ADC-AA-055 | Protein A-Duocarmycin ADC | Duocarmycins | |
| ADC-AA-049 | Protein G-MMAF ADC | MMAF (Monomethyl auristatin F) | |
| ADC-AA-027 | anti-MIgG(Fc)Fab-N-MMAF ADC | Noncleavable linkers | MMAF (Monomethyl auristatin F) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-TNF MAb (Clone 6)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13011)
- Anti-CD28 MAb (Clone 3)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS17006)
- Anti-FLT1 MAb (Clone 2)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5452)
- Citatuzumab-iFluor 680 (CAT#: ADC-FL-1270)
- Anti-PDCD1 MAb (Clone 35)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12247)
- Anti-FCER2 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3295)
- Anti-HIV-1 MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5360)
- Anti-TNFRSF10B MAb (Clone 1)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11189)
- Anti-CD5 MAb (Clone 15)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9415)
- Anti-CD22 MAb (Clone 5)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS1867)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
